Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. [electronic resource]
Producer: 20041220Description: 2031-7 p. digitalISSN:- 1526-632X
- Adolescent
- Adult
- Aged
- Antibody Specificity
- Antiviral Agents -- immunology
- Cell Line, Tumor
- Cytopathogenic Effect, Viral -- drug effects
- Disease Progression
- Disease-Free Survival
- Drug Resistance
- Encephalomyocarditis virus -- drug effects
- Female
- Follow-Up Studies
- Humans
- Incidence
- Interferon beta-1a
- Interferon beta-1b
- Interferon-beta -- antagonists & inhibitors
- Isoantibodies -- immunology
- Life Tables
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Neutralization Tests
- Prospective Studies
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.